• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Metagenomi, Inc. - Common Stock (NQ: MGX )

    4.700 +0.050 (+1.08%)
    Streaming Delayed Price Updated: 2:07 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 6,390
    Open 4.460
    Bid (Size) 4.660 (1)
    Ask (Size) 4.790 (1)
    Prev. Close 4.650
    Today's Range 4.460 - 4.700
    52wk Range 3.340 - 12.74
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    METAGENOMI ALERT: Bragar Eagel & Squire, P.C. is Investigating Metagenomi, Inc. on Behalf of Metagenomi Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire

    Performance

    YTD
    -54.41%
    -54.41%
    1 Month
    +30.56%
    +30.56%
    3 Month
    -33.14%
    -33.14%
    6 Month
    -54.41%
    -54.41%
    1 Year
    -54.41%
    -54.41%

    More News

    Read More
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Metagenomi, Inc. (MGX)
    From Kirby McInerney LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Metagenomi, Inc. (MGX) on Behalf of Investors
    From Law Offices of Frank R. Cruz
    Via Business Wire
    Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
    From Metagenomi, Inc.
    Via GlobeNewswire
    MGX Stock Earnings: Metagenomi Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
    From Metagenomi, Inc.
    Via GlobeNewswire
    Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025 Formula, Stock Soars
    Via Benzinga
    Exposures COVID-19
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire
    Via InvestorPlace
    Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
    From Metagenomi, Inc.
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Metagenomi to Present at Upcoming Scientific Meetings
    From Metagenomi, Inc.
    Via GlobeNewswire
    Metagenomi Reports Business Updates and Full Year 2023 Financial Results
    From Metagenomi, Inc.
    Via GlobeNewswire
    Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference
    From Metagenomi Technologies, LLC
    Via GlobeNewswire
    This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet
    Via The Motley Fool
    Topics Initial Public Offering
    Exposures Securities Market
    Metagenomi Announces Closing of Initial Public Offering
    From Metagenomi Technologies, LLC
    Via GlobeNewswire
    Gilead-Backed Kyverna Overshoots Raised IPO Expectations
    Via Talk Markets
    Topics Initial Public Offering
    Exposures Securities Market
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.